Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CIBACALCIN

CALCITONIN HUMAN

Standard Dose
0.5MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CIBACALCIN is listed in Drugs@FDA under application 018470 (NDA).

Marketing status: Discontinued Active ingredient CALCITONIN HUMAN Form and strength INJECTABLE;INJECTION - 0.5MG/VIAL Sponsor NOVARTIS Submission history Latest submission status date: 1997-11-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview CIBACALCIN is listed in Drugs@FDA under application 018470 (NDA). Marketing status: Discontinued Active ingredient CALCITONIN HUMAN Form and strength INJECTABLE;INJECTION - 0.5MG/VIAL Sponsor NOVARTIS Submission history Latest submission status date: 1997-11-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.